Enacting Active Survivorship: Implementation of Weight Management Strategies in Endometrial Cancer Survivors

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Observational
SUMMARY

This study is being done to understand how oncologists can engage a multidisciplinary team to help endometrial cancer survivors with obesity to engage in a weight management program and potentially start a weight loss medication. Obesity often impacts the future health and longevity of early-stage endometrial cancer survivors more than their cancer diagnosis. Patients will be referred to the KUMC OB/Gyn weight management clinic to discuss weight management options. * If patients decide to use medications for weight loss, then the study will collect data from their chart that is recorded as part of routine monitoring for patients on weight loss medications. * If patients decide not to use any medications, the study will monitor physical exam and lab data collected as part of their routine medical care. The study will also try to understand reasons why patients did or did not start using a weight loss medication.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: f
View:

• ≥18 years old

• ECOG 0-2

• BMI ≥ 30kg/m2

• Completed surgical staging with no evidence of residual disease

• Endometrioid endometrial adenocarcinoma, p53 wild type

• Stage 1

• Undergoing active surveillance +/- brachytherapy

Locations
United States
Kansas
University of Kansas Medical Center
RECRUITING
Kansas City
Contact Information
Primary
Principal Investigator
mjavellana@kumc.edu
913-588-0885
Backup
Co-investigator
yabedin@kumc.edu
913-588-1593
Time Frame
Start Date: 2025-03-25
Estimated Completion Date: 2030-10
Participants
Target number of participants: 50
Treatments
Endometrial cancer survivors with weight management
Survivors of low-risk early-stage endometrial cancer up to12 months post primary treatment with body mass index (BMI) ≥30 kg/m2
Related Therapeutic Areas
Sponsors
Leads: University of Kansas Medical Center

This content was sourced from clinicaltrials.gov